Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Comparative of Toxicity and Effectiveness of Lobaplation or Cisplatin Based Adjuvant Chemotherapy in Esophageal Carcinoma

NCT03413436 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT03413436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03413436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Comparative of Toxicity and Effectiveness of Lobaplation or Cisplatin Based Adjuvant Chemotherapy in Esophageal Carcinoma
Lead sponsor
Henan Cancer Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2018
Completion date
February 21, 2018
Enrollment
733 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer